MedPath

Effect of consumption of probiotic containing Saccharomyces boulardii to extended-spectrum beta-lactamases (ESBL)-producing Escherichia coli in carrier persons: A randomized controlled trial

Phase 3
Completed
Conditions
ESBL E. coli carriers
Registration Number
TCTR20180313002
Lead Sponsor
Department of Microbiology, Phramongkutklao College of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
68
Inclusion Criteria

- living in Phrapleng community, Sa Keaw Province, Thailand
- age over 18 years old
- Stool culture positive for ESBL E. coli
- consent to participate in the research

Exclusion Criteria

- Immunocompromised host eg. AIDs, immunosuppressant users etc.
- consummation of active microbiota food eg. curd, yogurt etc. at the time of intervention carry (3 weeks)
- taking antibiotics that effect ESBL bacteria; Carbapenems, Beta-lactamase inhibitor and Aminoglycosides at the time of intervention carry (3 weeks)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
prevalence of ESBL E. coli carriers after intervention in both groups of participants before and after intervention Screening test by stool culture on selective ESBL agar, confirmatory test by MALDI-TOF and combine
Secondary Outcome Measures
NameTimeMethod
/A N/A N/A
© Copyright 2025. All Rights Reserved by MedPath